| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1196.99 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1196.99/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.99 |
| Version | 20190517 |
| Status | active |
| Date | 2019-05-17T01:01:02-04:00 |
| Name | CPICRxNORMCapecitabineSCDG |
| Title | CPIC RxNORM capecitabine SCDG |
| Realm | us |
| Authority | hl7 |
| Description | We have NOT excluded any dose forms (such as topical), at this time, even though in some cases topical medications may not be subject to the same drug-gene interactions that are are seen with systemically administered medications. Elimu OID: 2019.05.14.11.08 |
| Purpose | (Clinical Focus: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having capecitabine as an ingredient.),(Data Element Scope: None),(Inclusion Criteria: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having capecitabine as an ingredient.),(Exclusion Criteria: None) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1196.99",
"meta": {
"versionId": "5",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Elimu Informatics Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-03-03"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2019-05-17"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.99",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1196.99"
}
],
"version": "20190517",
"name": "CPICRxNORMCapecitabineSCDG",
"title": "CPIC RxNORM capecitabine SCDG",
"status": "active",
"experimental": false,
"date": "2019-05-17T01:01:02-04:00",
"publisher": "Elimu Informatics Steward",
"description": "We have NOT excluded any dose forms (such as topical), at this time, even though in some cases topical medications may not be subject to the same drug-gene interactions that are are seen with systemically administered medications. \nElimu OID: 2019.05.14.11.08",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having capecitabine as an ingredient.),(Data Element Scope: None),(Inclusion Criteria: This value set contains all RxNorm codes of type Semantic Clinical Dose Form Group (TTY=SCDG) having capecitabine as an ingredient.),(Exclusion Criteria: None)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1158877",
"display": "capecitabine Oral Product"
},
{
"code": "1158878",
"display": "capecitabine Pill"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:0d7157bc-4e91-4247-83d5-89e2eec507aa",
"timestamp": "2025-05-23T19:14:12-04:00",
"total": 2,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1158877",
"display": "capecitabine Oral Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1158878",
"display": "capecitabine Pill"
}
]
}
}